Cargando…
DSCAM‐AS1 regulates the G(1)/S cell cycle transition and is an independent prognostic factor of poor survival in luminal breast cancer patients treated with endocrine therapy
DSCAM‐AS1 is one of the few intensively studied lncRNAs with high specific expression in luminal breast cancer. It is directly regulated by estrogen receptor α (ERα) and plays vital roles in tumor proliferation, invasion, and tamoxifen resistance. However, the detailed function of DSCAM‐AS1 in tumor...
Autores principales: | Sun, Wei, Li, An‐Qi, Zhou, Ping, Jiang, Yi‐Zhou, Jin, Xi, Liu, Yi‐Rong, Guo, Ya‐Jie, Yang, Wen‐Tao, Shao, Zhi‐Ming, Xu, Xiao‐En |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308059/ https://www.ncbi.nlm.nih.gov/pubmed/30430768 http://dx.doi.org/10.1002/cam4.1603 |
Ejemplares similares
-
Long non-coding RNA DSCAM-AS1 contributes to the tumorigenesis of cervical cancer by targeting miR-877-5p/ATXN7L3 axis
por: Liang, Jie, et al.
Publicado: (2020) -
PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer
por: Alfarsi, Lutfi H., et al.
Publicado: (2020) -
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer
por: Grote, Isabel, et al.
Publicado: (2021) -
A Novel Mouse Dscam Mutation Inhibits Localization and Shedding of DSCAM
por: Schramm, R. Dee, et al.
Publicado: (2012) -
A Review on the Carcinogenic Roles of DSCAM-AS1
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)